---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-035687"
form_type: "8-K"
ticker: "SYRA"
cik: "0001922335"
company_name: "Syra Health Corp"
filed_at: "2023-10-04T23:59:59+00:00"
generated_at: "2026-06-10T05:02:37.660972+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Syra Health prices upsized IPO of 1.615M units at $4.125/unit, raises ~$6.7M gross

## Summary
- IPO units priced at $4.125 each: one share Class A common + one warrant (exercise $6.50, 5-year term).
- Gross proceeds of approx. $6.7 million before underwriting discounts and expenses.
- Shares began trading on Nasdaq on Sept 29 under ticker SYRA; IPO closed Oct 3, 2023.
- Underwriters partially exercised over-allotment for 242,250 warrants at $0.01 each; option remains for 242,250 additional shares.
- Five new independent directors appointed effective Oct 3: Rogers, Dahlem, V. Reddy, Paranjape, A. Reddy; committee chairs named.

## SEC filing metadata
- accession: 0001493152-23-035687
- form_type: 8-K
- ticker: SYRA
- cik: 0001922335
- company_name: Syra Health Corp
- filed_at: 2023-10-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1922335/000149315223035687/0001493152-23-035687-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1922335/000149315223035687/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-035687
- JSON: https://secwatch.observer/filing/0001493152-23-035687.json
- Plain text: https://secwatch.observer/filing/0001493152-23-035687.txt

## Key facts
- Executive change
  Andrew Dahlem was appointed as Director at Syra Health Corp.
  - Action: appointed
  - Role: Director
  source text: Effective as of October 3, 2023, each of Sherron Rogers, Andrew Dahlem, Vijayapal Reddy, Ketan Paranjape, and Avutu Reddy were appointed to serve as members of Syra Health Corp.'s (the “Company’s”) board of directors (the “Board”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1922335/000149315223035687/0001493152-23-035687-index.htm
- Executive change
  Vijayapal Reddy was appointed as Director at Syra Health Corp.
  - Action: appointed
  - Role: Director
  source text: Effective as of October 3, 2023, each of Sherron Rogers, Andrew Dahlem, Vijayapal Reddy, Ketan Paranjape, and Avutu Reddy were appointed to serve as members of Syra Health Corp.'s (the “Company’s”) board of directors (the “Board”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1922335/000149315223035687/0001493152-23-035687-index.htm
- Executive change
  Avutu Reddy was appointed as Director at Syra Health Corp.
  - Action: appointed
  - Role: Director
  source text: Effective as of October 3, 2023, each of Sherron Rogers, Andrew Dahlem, Vijayapal Reddy, Ketan Paranjape, and Avutu Reddy were appointed to serve as members of Syra Health Corp.'s (the “Company’s”) board of directors (the “Board”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1922335/000149315223035687/0001493152-23-035687-index.htm
- Executive change
  Sherron Rogers was appointed as Director at Syra Health Corp.
  - Action: appointed
  - Role: Director
  source text: Effective as of October 3, 2023, each of Sherron Rogers, Andrew Dahlem, Vijayapal Reddy, Ketan Paranjape, and Avutu Reddy were appointed to serve as members of Syra Health Corp.'s (the “Company’s”) board of directors (the “Board”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1922335/000149315223035687/0001493152-23-035687-index.htm
- Executive change
  Ketan Paranjape was appointed as Director at Syra Health Corp.
  - Action: appointed
  - Role: Director
  source text: Effective as of October 3, 2023, each of Sherron Rogers, Andrew Dahlem, Vijayapal Reddy, Ketan Paranjape, and Avutu Reddy were appointed to serve as members of Syra Health Corp.'s (the “Company’s”) board of directors (the “Board”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1922335/000149315223035687/0001493152-23-035687-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.